{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:05:49Z","timestamp":1790255149172,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["ZIABC012157-02"],"award-info":[{"award-number":["ZIABC012157-02"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["ZIABC012157-02"],"award-info":[{"award-number":["ZIABC012157-02"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omton.2026.201260","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:49:16Z","timestamp":1780760956000},"page":"201260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of chimeric antigen receptors targeting the \u03b3\u03b4 T cell receptor"],"prefix":"10.1016","volume":"34","author":[{"given":"Lauren C.","family":"Cutmore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norris","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Amatya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Weissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle A.","family":"Natrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4362-9875","authenticated-orcid":false,"given":"James N.","family":"Kochenderfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201260_bib1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0161-5890(02)00034-2","article-title":"Structure of \u03b3\u03b4 T cell receptors and their recognition of non-peptide antigens","volume":"38","author":"Allison","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omton.2026.201260_bib2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/JLB.2MR1219-233R","article-title":"\u03b1\u03b2 and \u03b3\u03b4 T cell receptors: Similar but different","volume":"107","author":"Morath","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.omton.2026.201260_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00020","article-title":"\u03b3\u03b4 T lymphocytes in the diagnosis of human T cell receptor immunodeficiencies","volume":"6","author":"Garcill\u00e1n","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201260_bib4","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1073\/pnas.83.24.9596","article-title":"Genetic polymorphism and exon changes of the constant regions of the human T-cell rearranging gene gamma","volume":"83","author":"Lefranc","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2026.201260_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/biom12030381","article-title":"IMGT\u00ae Homo sapiens IG and TR Loci, Gene Order, CNV and Haplotypes: New Concepts as a Paradigm for Jawed Vertebrates Genome Assemblies","volume":"12","author":"Lefranc","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.omton.2026.201260_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","article-title":"\u03b3\u03b4 T cells: First line of defense and beyond","volume":"32","author":"Chien","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omton.2026.201260_bib7","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3389\/fimmu.2018.02389","article-title":"\u03b3\u03b4 T lymphocytes: An effector cell in autoimmunity and infection","volume":"9","author":"Shiromizu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201260_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/DAD.0000000000002041","article-title":"Gamma\/Delta (\u03b3\u03b4) T Cells: The Role of the T-Cell Receptor in Diagnosis and Prognosis of Hematologic Malignancies","volume":"44","author":"Goyal","year":"2022","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.omton.2026.201260_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","article-title":"Gamma-delta T-cell lymphomas","volume":"6","author":"Tripodo","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201260_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic factors of hepatosplenic T-cell lymphoma clinicopathologic study of 28 cases","volume":"40","author":"Yabe","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.omton.2026.201260_bib11","first-page":"264","article-title":"\u03b3\u03b4 and \u03b1\u03b2 T-cell acute lymphoblastic leukemia: Comparision of their clinical and immunophenotypic features","volume":"90","author":"Matos","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.omton.2026.201260_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1599637","article-title":"Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor","volume":"8","author":"Pui","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omton.2026.201260_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.exphem.2021.12.191","article-title":"Recent advances in T-cell lymphoid neoplasms","volume":"106","author":"Bigas","year":"2022","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.omton.2026.201260_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1189\/jlb.3RU0914-443R","article-title":"Role of gamma-delta (gammadelta) T cells in autoimmunity","volume":"97","author":"Paul","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.omton.2026.201260_bib15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.90.2.720","article-title":"Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors","volume":"90","author":"Eshhar","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2026.201260_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41571-021-00530-z","article-title":"A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains","volume":"18","author":"Cappell","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201260_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.leu.2403302","article-title":"Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia","volume":"18","author":"Imai","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2026.201260_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/CJI.0b013e3181ac6138","article-title":"Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor","volume":"32","author":"Kochenderfer","year":"2009","journal-title":"J. Immunother."},{"key":"10.1016\/j.omton.2026.201260_bib19","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s43018-021-00241-5","article-title":"Engineering-enhanced CAR T cells for improved cancer therapy","volume":"2","author":"Milone","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.omton.2026.201260_bib20","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.ymthe.2017.07.013","article-title":"Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains","volume":"25","author":"Alabanza","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201260_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt0102-70","article-title":"Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR\u03b6\/CD28 receptor","volume":"20","author":"Maher","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omton.2026.201260_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omto.2023.07.001","article-title":"Development of a bicistronic anti-CD19\/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions","volume":"30","author":"Lam","year":"2023","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omton.2026.201260_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41467-019-14119-9","article-title":"Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains","volume":"11","author":"Lam","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201260_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1089\/hum.2020.215","article-title":"Design and assessment of novel Anti-CD30 chimeric antigen receptors with human antigen-recognition domains","volume":"32","author":"Choi","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2026.201260_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-019-0737-3","article-title":"Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma","volume":"26","author":"Brudno","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201260_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrclinonc.2017.128","article-title":"Chimeric antigen receptor T-cell therapies for lymphoma","volume":"15","author":"Brudno","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201260_bib27","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41577-024-01035-3","article-title":"Chimeric antigen receptor T cell therapy for autoimmune disease","volume":"24","author":"Chung","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2026.201260_bib28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ymthe.2023.12.018","article-title":"Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain","volume":"32","author":"Mikkilineni","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201260_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10555-024-10219-1","article-title":"CAR T-cell therapy to treat multiple myeloma: current state and future directions","volume":"44","author":"Reddy","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.omton.2026.201260_bib30","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41591-019-0549-5","article-title":"Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR","volume":"25","author":"Ghorashian","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201260_bib31","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.ymthe.2017.04.017","article-title":"Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia","volume":"25","author":"Arcangeli","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201260_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bbrc.2020.03.071","article-title":"Impact of scFv structure in chimeric antigen receptor on receptor expression efficiency and antigen recognition properties","volume":"527","author":"Fujiwara","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omton.2026.201260_bib33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/protein\/6.8.989","article-title":"An improved linker for single-chain fv with reduced aggregation and enhanced proteolytic stability","volume":"6","author":"Whitlow","year":"1993","journal-title":"Protein Eng."},{"key":"10.1016\/j.omton.2026.201260_bib34","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1073\/pnas.85.16.5879","article-title":"Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli","volume":"85","author":"Huston","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2026.201260_bib35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-021-01326-5","article-title":"Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells","volume":"27","author":"Singh","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201260_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/2326-6066.CIR-14-0127","article-title":"The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity","volume":"3","author":"Hudecek","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omton.2026.201260_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.cji.0000161397.96582.59","article-title":"The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens","volume":"28","author":"Guest","year":"2005","journal-title":"J. Immunother."},{"key":"10.1016\/j.omton.2026.201260_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat6753","article-title":"Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function","volume":"11","author":"Salter","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.omton.2026.201260_bib39","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1380764","article-title":"Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer","volume":"7","author":"Priceman","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.omton.2026.201260_bib40","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037929","article-title":"Memory t-cell heterogeneity and terminology","volume":"13","author":"Muroyama","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.omton.2026.201260_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41375-021-01385-0","article-title":"Chimeric antigen receptor T cells for gamma\u2013delta T cell malignancies","volume":"36","author":"Wawrzyniecka","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2026.201260_bib42","author":"He"},{"key":"10.1016\/j.omton.2026.201260_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PAI.0000000000000650","article-title":"Immunohistochemical Detection of gamma\/delta T Lymphocytes in Formalin-fixed Paraffin-embedded Tissues","volume":"27","author":"Jungbluth","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.omton.2026.201260_bib44","author":"Van Der Vliet Johannes"},{"key":"10.1016\/j.omton.2026.201260_bib45","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/eji.1830190907","article-title":"Non-random expression of T cell receptor gamma and delta variable gene segments in functional T lymphocyte clones from human peripheral blood","volume":"19","author":"Borst","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omton.2026.201260_bib46","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/mt.2009.83","article-title":"Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo","volume":"17","author":"Milone","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201260_bib47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.leu.2404112","article-title":"TCRgammadelta+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta+ T-cells","volume":"20","author":"Sandberg","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2026.201260_bib48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.168.2.761","article-title":"Characterization of a third form of the human T cell receptor \u03b3\/\u03b4","volume":"168","author":"Hochstenbach","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2026.201260_bib49","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.2021010930","article-title":"CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel","volume":"138","author":"Plaks","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201260_bib50","doi-asserted-by":"crossref","first-page":"14342","DOI":"10.1073\/pnas.0804105105","article-title":"Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer","volume":"105","author":"Rabinovich","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:35:10Z","timestamp":1790253310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926001360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2950329926001360"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201260","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of chimeric antigen receptors targeting the \u03b3\u03b4 T cell receptor","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201260"}}